American and German researchers have created an experimental drug, ABT-450, that they boast can treat Hepatitis C with 95 percent success rate. The researchers have claimed that the drug was found effective in patients who failed to respond to earlier treatments. The drug has been developed by AbbVie, which has funded the study. The patients were found responding well to the experimental … [Read more...]
You are here: Home / Archives for Hepatitis C experimental drug